Shibuya Showcases End-to-End Pharmaceutical Systems for Advanced Aseptic Manufacturing
How integrated isolators, sterilization platforms, and filling technologies strengthen sterility, compliance, and efficiency in global drug production.
www.shibuyahoppmann.com
A Comprehensive Approach to Pharmaceutical Manufacturing
Shibuya Corporation, a long-established leader in precision automation, is highlighting its full portfolio of pharmaceutical systems engineered to meet the most stringent global standards for sterility, quality and regulatory compliance. The company supports pharmaceutical and biopharmaceutical manufacturers across a wide range of container and closure systems—from aseptic filling to final packaging—ensuring a controlled and repeatable production environment for complex sterile drug products.
Isolator Technologies Designed for Modern Aseptic Processing
Shibuya’s isolator platforms cover sterility testing, high-potency containment for oncology and other potent compounds, and full aseptic manufacturing applications. Each isolator is engineered to deliver consistent air quality, environmental decontamination and contamination control in line with EU Annex 1 and international cGMP requirements.
These systems are widely deployed in applications such as parenteral injections, vaccines, cell-culture-derived therapies, combination products and cytotoxic preparations. By providing reliable microbiological risk reduction, the isolators support stable, contamination-free production even under demanding process conditions.
Integrated Sterilization and Decontamination Systems
To further reinforce contamination control, Shibuya offers vapor-phase hydrogen peroxide (VPHP) decontamination systems for isolators, closed RABs and cleanrooms. These systems apply controlled sterilization cycles to eliminate microbial contaminants on equipment surfaces and packaging materials.
The integration of sterilization and decontamination capabilities into broader manufacturing workflows enables pharmaceutical producers to maintain consistent sterility assurance and reduce the operational risk typically associated with complex aseptic environments.
One of the Industry’s Most Complete Filling System Portfolios
Shibuya also delivers a highly versatile range of filling technologies, supporting vials, ampoules, syringes, nested containers, cartridges, drop-dose solutions, aseptic powders and lyophilized products. These systems incorporate precision dosing, adaptable configurations and advanced process control to ensure accuracy and efficiency at scale.
Their compatibility with glass, plastic and flexible packaging formats allows manufacturers to tailor production lines to specific drug products and market requirements. The company also provides custom-engineered systems, enabling new sterile drug delivery concepts to be realized and validated within a single manufacturing partner.
Integrated Upstream and Downstream Capabilities
Complementing its isolators and filling systems, Shibuya offers automated CIP/SIP compounding and formulation technologies, sterilizing filtration skids and advanced washer-depyrogenation, lyophilizer interface and inspection systems. These solutions integrate tightly with Shibuya Validation Services to streamline qualification and regulatory compliance.
Environmental monitoring automation further supports manufacturers in minimizing risk and ensuring continuous adherence to stringent contamination-control criteria.
Advancing Global Aseptic Manufacturing Standards
Through its focus on innovation, reliability and regulatory alignment, Shibuya continues to expand what is technically possible in aseptic drug manufacturing. Its integrated systems are trusted by pharmaceutical companies worldwide for improving operational efficiency, reducing contamination risk and upholding the highest levels of sterility assurance.
More information on Shibuya’s pharmaceutical systems is available here.
www.shibuya.com
